Innate Pharma S.A. ADR (IPHA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | IPHA | OPT | LCTX | ||
| Company | Innate Pharma S.A. ADR | Opthea Ltd ADR | Lineage Cell Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE Arca | ||
| Open | 2.63 | 3.43 | 1.0800 | ||
| High | 2.71 | 3.49 | 1.0900 | ||
| Low | 2.63 | 3.38 | 1.0201 | ||
| Last | 2.71 | 3.41 | 1.0800 | ||
| Change | +0.14 | -0.17 | +0.0200 | ||
| % Change | +5.28% | -4.75% | +1.89% | ||
| Volume | 12,400 | 7,700 | 1,361,186 | ||
| 20-Day Average Volume | 3,880 | 31,175 | 1,000,155 | ||
| Previous Close | 2.57 | 3.58 | 1.0600 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 2.51 | 3.46 | 1.1255 | ||
| 20-Day Raw Stochastic | 100.00% | 24.71% | 15.77% | ||
| 20-Day Relative Strength | 55.51% | 47.69% | 45.52% | ||
| Weighted Alpha | -6.16 | +18.41 | -21.73 | ||
| Today's Opinion | Hold | 48% Buy | 56% Sell | ||
| Previous Opinion | 48% Sell | 72% Buy | 56% Sell | ||
| Last Month's Opinion | 100% Sell | 56% Buy | 32% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +7.11% since 05/10/24 | -5.80% since 05/10/24 | -7.69% since 05/10/24 | ||
| Low | 2.43 on 05/15/24 | 3.38 on 05/17/24 | 1.0201 on 05/17/24 | ||
| High | 2.71 on 05/17/24 | 3.76 on 05/13/24 | 1.1700 on 05/13/24 | ||
| 1-Month | |||||
| %Chg | +12.44% since 04/17/24 | +0.29% since 04/17/24 | -16.28% since 04/17/24 | ||
| Low | 2.25 on 04/19/24 | 3.20 on 05/08/24 | 1.0201 on 05/17/24 | ||
| High | 2.71 on 05/17/24 | 4.05 on 05/09/24 | 1.3999 on 05/06/24 | ||
| 3-Month | |||||
| %Chg | +6.69% since 02/16/24 | +15.20% since 02/16/24 | -4.42% since 02/16/24 | ||
| Low | 2.25 on 04/19/24 | 2.96 on 02/20/24 | 1.0201 on 05/17/24 | ||
| High | 3.15 on 04/08/24 | 4.40 on 04/01/24 | 1.6100 on 03/28/24 | ||
| 6-Month | |||||
| %Chg | +10.61% since 11/17/23 | +79.47% since 11/17/23 | +13.68% since 11/17/23 | ||
| Low | 2.25 on 04/19/24 | 1.88 on 11/20/23 | 0.8414 on 02/01/24 | ||
| High | 3.15 on 04/08/24 | 4.40 on 04/01/24 | 1.6100 on 03/28/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 208,136 | 209,054 | 200,126 | ||
| Shares Outstanding, K | 80,861 | 58,395 | 188,798 | ||
| Annual Sales | 66,710,000 | 110,000 | 8,950,000 | ||
| Annual Net Income | -8,190,000 | -142,520,000 | -21,490,000 | ||
| Last Quarter Sales | N/A | N/A | 1,440,000 | ||
| Last Quarter Net Income | N/A | N/A | -6,540,000 | ||
| 60-Month Beta | 0.38 | 1.24 | 1.39 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | N/A | -0.04 on 05/09/24 | ||
| Latest Earnings Date | 05/14/24 | 09/12/23 | 05/09/24 | ||
| Most Recent Dividend | N/A | N/A | 0.080 on 12/15/03 | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||